Caption Management, LLC Immuno Gen, Inc. Put Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $9.8 Million - $23.5 Million	786,200 Added 5697.1%	800,000 $23.7 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $1.12 Million - $1.58 Million	-79,500 Reduced 85.21%	13,800 $219,000
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $349,875 - $1.87 Million	93,300 New	93,300 $1.76 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $185,000 - $383,000	50,000 Added 33.33%	200,000 $1.29 Million
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $301,250 - $738,750	125,000 Added 500.0%	150,000 $405,000
Q4 2018 Jan 30, 2019	BUY	$3.94 - $9.7 $98,500 - $242,499	25,000 New	25,000 $121,000
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $428,400 - $546,750	-45,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $301,500 - $582,750	45,000 New	45,000 $474,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.